New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
10:07 EDTGPS, RF, ROP, SDRL, GME, OSIS, GMCR, MYLOn The Fly: Analysts Upgrade Summary
Today's noteworthy upgrades include: Gap (GPS) upgraded to Hold from Sell at Canaccord...Regions Financial (RF) upgraded to Outperform from Neutral at RW Baird...Roper Industries (ROP) upgraded to Buy from Neutral at Citigroup...Seadrill (SDRL) upgraded to Outperform from Neutral at Credit Suisse...GameStop (GME) upgraded to Buy from Above Average at Caris...OSI Systems (OSIS) upgraded to Outperform from Perform at Oppenheimer...Green Mountain (GMCR) upgraded to Buy from Neutral at Dougherty...Mylan (MYL) upgraded to Outperform from Market Perform at Leerink.
News For GPS;RF;ROP;SDRL;GME;OSIS;GMCR;MYL From The Last 14 Days
Check below for free stories on GPS;RF;ROP;SDRL;GME;OSIS;GMCR;MYL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 22, 2014
05:33 EDTGMEGameStop FY14 outlook may prove conservative, says Piper Jaffray
Piper Jaffray believes GameStop's outlook for FY14 may prove conservative as second half same-store-sales estimates look low. Piper views GameStop's Q2 results as solid and raised its price target for shares to $53 from $52 while keeping an Overweight rating on the stock.
August 21, 2014
18:22 EDTGPS, GMEOn The Fly: After Hours Movers
Subscribe for More Information
16:09 EDTGMEGameStop up 10.6% after reporting Q2 results, guidance for Q3, FY14
Subscribe for More Information
16:08 EDTGMEGameStop sees FY14 EPS $3.40-$3.70, consensus $3.68
Subscribe for More Information
16:07 EDTGMEGameStop sees Q3 EPS 58c-64c, consensus 59c
Sees Q3 SSS up 1%-5%.
16:06 EDTGPSGap announces plans to open first franchise-operated Gap stores in India in 2015
Subscribe for More Information
16:05 EDTGPSGap raises FY14 EPS view to $2.95-$3.00, consensus $2.95
The company updated its guidance forFY14 diluted EPS to be in the range of $2.95-$3.00, to reflect the 5c related to the gain on asset sale. For FY14, the company continues to expect capital spending to be approximately $750M in support of its outlined strategies.
16:02 EDTGMEGameStop reports Q2 EPS 22c, consensus 18c
Subscribe for More Information
16:01 EDTGPSGap reports Q2 EPS 75c, consensus 69c
Subscribe for More Information
15:15 EDTGME, GPSNotable companies reporting after market close
Subscribe for More Information
14:52 EDTGMEGameStop technical comments ahead of results
Subscribe for More Information
09:57 EDTGMEGameStop August weekly 41 straddle priced for 6.7% move into Q2
06:26 EDTGMEGameStop August weekly volatility elevated into Q2 and revenue outlook
GameStop August weekly call option implied volatility is at 163, September is at 47, January is at 40; compared to it 26-week average of 43 according to Track Data, suggesting large near term price movement into the expected release of Q2 today.
August 20, 2014
11:44 EDTMYLMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
11:33 EDTMYLMylan into second round of bidding for GSK drug portfolio, WSJ reports
Subscribe for More Information
August 19, 2014
11:44 EDTMYLMylan launches generic Precedex Injection
Subscribe for More Information
09:28 EDTGMEGameStop says CEO underwent unexpected surgery for tumor
GameStop disclosed in a regulatory filing that late last week Paul Raines, its CEO, underwent unexpected surgery during which a "very small, cancerous tumor was identified and successfully removed from an easily accessible part of the brain." The company added, "Because it was found very early, his doctors have advised him that his prognosis for a full and complete recovery is very good. The next step is for Paul to undergo preventive chemotherapy. Recovery from this process is expected to take about six weeks. This regimen will restrict his travel during that period, but will not interfere with his continued leadership of the Company." Daniel DeMatteo, Executive Chairman, said, "Speaking for the Board, we have every confidence in Paulís continued leadership and wish him a speedy recovery. While he recovers, our highly-tenured executive team will ensure that our business continues without interruption."
09:01 EDTGMCRKeurig Green Mountain estimates raised at SunTrust
Subscribe for More Information
06:11 EDTGMEGameStop FY14 guidance likely in-line, says Piper Jaffray
Subscribe for More Information
August 18, 2014
10:06 EDTMYLLannett surges after upbeat Q4, FY14 outlook
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use